Analysis of siRNA specificity on targets with double-nucleotide mismatches by Dahlgren, Cecilia et al.
Published online 17 April 2008 Nucleic Acids Research, 2008, Vol. 36, No. 9 e53
doi:10.1093/nar/gkn190
Analysis of siRNA specificity on targets with
double-nucleotide mismatches
Cecilia Dahlgren
1,*, Hong-Yan Zhang
1, Quan Du
2, Maria Grahn
1, Gunnar Norstedt
1,
Claes Wahlestedt
3 and Zicai Liang
1,2
1Department of Molecular Medicine and Surgery, Karolinska Institutet, CMM L8:01, 171 76 Stockholm, Sweden,
2Institute of Molecular Medicine, Peking University, Beijing 100871, China and
3Neuroscience Discovery,
Scripps Florida, 5353 Parkside Drive RF2, Jupiter, FL 33458, USA
Received December 6, 2007; Revised March 29, 2008; Accepted April 1, 2008
ABSTRACT
Although RNA interference as a tool for gene knock-
down is a great promise for future applications, the
specificity ofsmallinterfering RNA(siRNA)-mediated
gene silencing needs to be thoroughly investigated.
Most research regarding siRNA specificity has
involvedanalysisofaffectedoff-targetgenesinstead
of exploring the specificity of the siRNA itself. In this
study we have developed an efficient method for
generating a siRNA target library by combining a
siRNA target validation vector with a nucleotide
oligomix. We have used this library to perform an
analysis of the silencing effects of a functional siRNA
towards its target site with double-nucleotide mis-
matches. The results indicated that not only the
positions of the mismatched base pair have an
impact on silencing efficiency but also the identity
of the mismatched nucleotide. Our data strengthen
earlier observations of widespread siRNA off-target
effects and shows that  35% of the double-mutated
target sites still causes knockdown efficiency of
>50%. We also provide evidence that there may be
substantial differences in knockdown efficiency
depending on whether the mutations are positioned
within the siRNA itself or in the corresponding
target site.
INTRODUCTION
Since the ﬁnding of siRNAs as mediators of gene
expression knockdown, ﬁrst discovered in Caenorhabditis
elegans (1), great expectations have been laid on the
mechanism of RNA interference (RNAi) and the use of
siRNA as a tool for functional gene studies. Numerous
studies have also explored RNAi as a potential
therapeutic mediator for cancer treatment and viral
diseases like HIV as well as for drug target discovery
(2–4). However, what ﬁrst seemed as a straightforward
and highly eﬀective tool for posttranscriptional gene
silencing turned out to involve more obstacles than ﬁrst
anticipated. Nonspeciﬁc side eﬀects, such as antiviral
responses caused by in vitro-transcribed siRNAs and oﬀ-
target eﬀects resulting in unspeciﬁc knockdown of
nontargeted genes, are issues that need to be resolved
before siRNA can be used as a reliable tool for gene
knockdown in various diseases (5–9).
As a result, a great deal of RNAi research has been
performed with the aim to deﬁne the distinct functions of
individual siRNA molecules and what features are crucial
for its eﬀectiveness and speciﬁcity. The majority of these
analyses have been conducted by altering the siRNA
sequence itself and monitoring the resulting knockdown
pattern (10). This type of data generates a well-deﬁned
analysis of each mutated siRNA molecule but does not
give a complete and true picture of all possible targets of a
single siRNA molecule. Alteration of the siRNA sequence
changes its sequence-speciﬁc characteristics and aﬀects the
thermal stability, which determines the siRNA’s ability to
incorporate into the RNA-induced silencing complex
(RISC) (11). Low internal stability at the 30 sense strand
facilitates strand selection and RISC incorporation,
whereas very low or very high internal stability tend to
cause reduced target aﬃnity and ineﬀective unwinding,
respectively (12). These sequential eﬀects all have impact
on siRNA functionality and therefore limit the conclu-
sions you can draw from analysis of siRNA speciﬁcity and
the possible oﬀ-target eﬀects caused by using sequence-
modiﬁed siRNAs.
Other studies have used global gene expression analyses
to evaluate the eﬀects of siRNAs other than the expected
knockdown of the target gene expression (7). In this study,
we use an alternative method to investigate siRNA
speciﬁcity. By altering the target site of a functional
siRNA, instead of altering the siRNA sequence itself, we
overcome the possible conformational changes in siRNA
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analyzed single-base mutations of the 19-base target of a
functional siRNA. Here, we analyze multiple combina-
tions of double-nucleotide mismatches of the same target.
We have prepared and optimized a straightforward and
cost eﬀective method to generate a siRNA target library
by combining the siQuant luciferase expression vector and
a single-tube chip-synthesized oligomix, containing all
possible combinations of double mutations in the 19-nt
long target sequence of the functional siCD46 (14). This
method avoids the cumbersome procedure of multiple
transformation reactions of all unique constructs and
provides a relatively fast generation of a large siRNA
target library to utilize for siRNA speciﬁcity studies. In
this study we provide further insight in the ﬁeld of siRNA
oﬀ-target eﬀects by showing that double mutations in the
siRNA target site still give rise to a substantial amount of
remaining knockdown activity by its corresponding
siRNA. We also show that nucleotide alterations in the
antisense strand of an siRNA molecule creates a diﬀerent
knockdown pattern when compared to the knockdown
eﬃciency of a wild type siRNA’s ability to suppress a
target site with corresponding mutations.
MATERIALS AND METHODS
Oligodesign and plasmid insert preparation
The target of siCD46 (XM_036622, nucleotides 604–622)
was used as a template to create our 19-nt double-mutated
siRNA targets. We designed a total of 1539 target
sites, each containing double-nucleotide mismatches in
all possible combinations (Table 1). The oligos consists of
a BglII restriction site at the 50 region followed by the
siCD46 target site and a 30 restriction site for ApaI. The
sequences were ordered in a single-tube oligomix (Atactic
Technologies Inc). The oligomix was PCR ampliﬁed using
the ﬂanking primers CD46-F3T7 (50-TAATACGACTC
ACTATAGGGGGTACAGCGGAGAT-30) and CD46-
R3T7 (50-TAATACGACTCACTATAGGGAGCCTGT
ACTGGG-30), giving a product of 85 bp in length
(Figure 1). Several PCR reactions were pooled and
ethanol precipitated to obtain a high concentration. The
puriﬁed PCR product was cleaved with restriction
enzymes FastDigest ApaI and BglII (Fermentas GmbH,
St. Leon-Rot, Germany) followed by analysis on a 2%
MetaPhor agarose gel for veriﬁcation of correct size (33
bp). The forward and reverse strands of the wild type
target of siCD46 were ordered separately and annealed to
form a ready-to-ligate target sequence. Sense strand: 50-
GATCACACTTATTGGAGAGAGCACGAGGCGGC
C-30 and the antisense strand: 50-GCCTCGTGCTCTC
TCCAATAAGTGT-30. All nucleotides except the oligo-
mix were purchased from MWG Biotech, Ebersberg,
Germany.
Construction of siQuant-CD46 vector
In this study, we used the previously described siRNA
validation vector siQuant to analyze siRNA speciﬁcity
(14). To generate circular constructs of the siQuant vector
and the siCD46-target restriction products, we performed
Table 1. The 19-mer target sequences were designed to represent every possible double-nucleotide mismatch,
a total of 1539 variations
Sequence name siQuant CD46 target oligo
CD6 wt-target CTTATTGGAGAGAGCACGA
BglII ApaI
siQ46-lA_2A CAGCGG AGATCT CA AATATTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_2C CAGCGG AGATCT CA ACTATTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_2G CAGCGG AGATCT CA AGTATTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_3A CAGCGG AGATCT CA ATAATTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_3C CAGCGG AGATCT CA ATCATTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_3G CAGCGG AGATCT CA ATGATTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_4C CAGCGG AGATCT CA ATTCTTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_4G CAGCGG AGATCT CA ATTGTTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_4T CAGCGG AGATCT CA ATTTTTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_5A CAGCGG AGATCT CA ATTAATGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_5C CAGCGG AGATCT CA ATTACTGGAGAGAGCACGA TA GGGCCC AGTACA
siQ46-lA_5G CAGCGG AGATCT CA ATTAGTGGAGAGAGCACGA TA GGGCCC AGTACA
etc.
The mutations are marked in bold letters. Target sites for restriction enzymes BglII and ApaI were introduced in
the 50 and 30 of the target site respectively to enable subsequent ligation to the siQuant vector (underlined
sequences). In this table only the ﬁrst 15 combinations are listed.
Figure 1. The oligomix containing all 1539 sequence variations of the siCD46 target site were PCR ampliﬁed with ﬂanking primers resulting in
a 85-bp long DNA molecule. The target sequence in this ﬁgure represents the wild-type version.
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vector,  25 ng of CD46-insert restriction product, 1U T4
DNA Ligase (Invitrogen Ltd, Paisley, PA, UK) at a ﬁnal
volume of 20ml. 5ml of the ligation reaction was then
analyzed on 0.6% agarose gel and the remaining 15 ml
were diluted 1:4 in 45 ml TE. 5 ml of this dilution was used
for transformation of 50 ml Max-eﬃciency DH5a cells
(Invitrogen) according to the manufacturer’s protocol.
200ml of the transformation reaction was then spread on
prewarmed LB Agar plates containing 50mg/l ampicillin
and incubated in 378C overnight. All positive clones were
then picked and inoculated in 1.4ml LB media with
ampicillin (50mg/l) for 16h at 378C.
siQ-CD46 target identification
To identify which sequence that had been inserted in the
vector for each positive clone, a small amount of each
overnight culture was used for subsequent pyrosequencing
analysis on a PSQTM96 instrument (Biotage AB,
Uppsala, SwedenBiotage). The prepyrosequencing PCR
was carried out with the primers pyro-F: 50-ATCCGCA
CCATGGGCTGT-30 and the biotinylated pyro-R-biot:
50-CTCTCCAGCGGTTCCATCTT-30. The reaction was
carried out in 958C for 3min; 35 cycles of 958C for 30s,
658C for 30s, 728C for 40s; 728C for 5min. 5 ml of the
PCR product was analyzed on 2% agarose gel for
visualization of band of correct size: 132 bp. The
pyrosequencing procedure was carried out using the
sequencing primer pyro-S: 50-CATGGGCTGTGAGA
TC-30 and according to manufacturer’s protocol. The
resulting pyrograms were transferred to Word documents
and the sequences analyzed manually. Positive clones of
siQuant vectors with correct and unique inserts were
puriﬁed with Qiagens’s QIAprep 96 Turbo Miniprep kit.
Concentrations were measured on a ND-1000 Spec-
trophotometer (NanoDrop Technologies, Wilmington,
DE, USA).
Cell transfections
Human embryonic kidney cells (HEK293A) were cultured
with GIBCO Dulbecco’s modiﬁed Eagle’s medium
(Invitrogen) containing 10% fetal bovine serum and
1 Penicillin–Streptomycin–Glutamine (Invitrogen). For
large-scaletransfectionexperiments, thecellswereseededin
96-well plates and grown for 24h. The conﬂuence was
about 50% for the time of transfection. The cells were
co-transfected with 0.08 mg of the diﬀerent siQ-CD46
mutants together with 0.008 mg of pRL-TK and 13 nM
of siCD46, using 0.2% Lipofectamine2000 (Invitrogen),
GIBCO Opti-Mem media (Invitrogen) in a ﬁnal volume of
100ml. Transfections were carried out for 24h with a media
change after 4h. For the comparative study of knockdown
eﬃciency between mutations in siRNA strand versus
mutations in its corresponding targets site, transfections
were carried out in 24-well plates and plasmid concentra-
tions were 0.17 and0.017mg forfusionconstructs andpRL-
TK, respectively. All samples were analyzed in triplicates.
The siCD46 sequences are as follows: wt-sense: 50-CU
UAUUGGAGAGAGCACGA-30, and wt-antisense: 50-UC
GUGCUCUCUCCAAUAAG-30; si46-9T_17A-sense: 50-C
UUAUUGGUGAGAGCAAGA-30, si46-9T_17A-anti-
sense: 50-UCUUGCUCUCACCAAUAAG-30; si46-3A_14C
-sense: 50-CUAAUUGGAGAGACCACGA-30,s i 4 6 -
3A_14C-antisense: 50-UCGUGGUCUCUCCAAUUAG-30;
si46-2C_8A-sense: 50-CCUAUUGAAGAGAGCACGA-30,
si46-2C_8A-antisense: 50- UCGUGCUCUCUUCAAUA
GG-3’.Thenamesofthesequence-alteredsiRNAscorrespond
to the sequence substitutions in the DNA sequence of the
corresponding siQuanttarget sites.
Fluorometeranalysis
At 24h posttransfection, the media was removed and the
cells washed with a suﬃcient amount of phosphate
buﬀered saline and treated with 20 ml passive lysis buﬀer
(PLB 1X, Promega Corporation, Madison, WI, USA) for
each well of the 96-well plates and 120 ml for each well in
the 24-well plates. The samples were incubated on
rocking tables for 15min in room temperature. To
measure siRNA silencing eﬃciency of our mutated
target sites, the Dual-Luciferase Reporter Assay System
(Promega) was used to detect luciferase expression. This
was feasible since the CD46-targets were fused with the
reporter gene, hence giving a luciferase expression
proportional to the siRNA silencing eﬃciency. The
Dual-Luciferase System was performed according to the
standard protocol from Promega Corporation. Samples
from the transfection in the 96-well were analyzed on a
ﬂuorometer (NOVOstar, BMG Labtechnologies GmbH,
Germany). The ﬁreﬂy luciferase signal was normalized to
the renilla luciferase signal for each sample. All siQuant
constructs were transfected with or without siCD46 to
obtain the relative silencing eﬃciency for each unique
clone.
RESULTS
Generationof siQuant CD46-target library
By using a nucleotide oligomix we were able to generate a
large set of double-mutated target sequences for the
functional siRNA siCD46. Correct inserts were veriﬁed
by Pyrosequencing. The sequences surrounding the two
restriction sites were also analyzed for consistency and
only plasmids with the exactly correct sequence were
selected for future transfection. This is of importance
because even a single nucleotide substitution, insertion or
deletion can change the reading frame and subsequent
transcription. About 50% of all positive colonies were
veriﬁed as correct siQuant-CD46-target constructs.
Following transfection assays showed that the majority
of the siQuant-CD46-target constructs obtained by this
method were functional and a total amount of 709 out of
1539 possible constructs were analyzed in this study
(Supplementary Table 1 a–c).
Silencing effects of siCD46 on targetsites
withdouble-nucleotide mismatches
The fusion luciferase reporter plasmids were used for
analysis of siRNA target speciﬁcity in a cell-based
assay system and validated by Dual-Luciferase Reporter
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proportional to the siCD46-target expression, which
makes it possible to validate the siRNA speciﬁcity by its
ability to repress luciferase activity. Each siQuant reporter
plasmid was co-transfected with the renilla luciferase
expressing pRL-TK control plasmid. To compensate for
possible variations in expression eﬃciency, the luciferase
activity values were normalized to the expression levels of
renilla luciferase and each reporter plasmid was also
transfected both in absence or presence of siCD46 to
verify that the knockdown eﬃciency corresponds to every
reporter plasmids own ability to express ﬁreﬂy luciferase.
The resulting data shows remaining expression levels of
ﬁreﬂy luciferase (Supplementary Table 1 a–c). To facilitate
the comprehensibility of the large data set, the expression
levels were categorized into diﬀerent subgroups and
visualized in a colour-coded chart ranging from green—
symbolizing low expression levels (eﬃcient knockdown
ability)—to red/black to symbolize high expression levels,
i.e. reduced knockdown ability (Figure 2).
The knockdown eﬃciency of the siCD46 when targeting
a wild type reporter is  92% (13). Out of our target
library of 709 reporter plasmids, 18 (3%) double-mutated
constructs gave a knockdown eﬃciency of >80%, 123
(17%) of the constructs resulted in 60–80% knockdown
and 318 (45%) of them reduced the knockdown ability to
Figure 2. Color-coded expression chart visualizing positional and regional trends for siCD46 knockdown eﬃciency and tolerance towards double-
mutations in its speciﬁc target site. The vertical axis represents the position of the ﬁrst mutation and the horizontal axis represents the position of the
second mutation. The cross-section of each pair illustrates the remaining luciferase expression of each clone. Seven hundred and nine out of 1539
diﬀerent combinations were identiﬁed and analyzed. These clones are each represented in the chart with a color corresponding to the remaining
expression activity after targeting with siCD46. Dark green represents <10% remaining expression activity, lime green: <20%, light green: <30%,
yellow: 30–40%, pink: >40%, red: >50% and black: >80% remaining activity. Light gray represents wild type target sequence and white
nonidentiﬁed clones.
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<20% knockdown which is considered to be nonsigniﬁ-
cant down regulation when it comes to siRNA eﬃciency.
It is remarkable that 227 (35%) of analyzed construct
causes a silencing eﬃciency of more than 50%.
Different tolerance regionsfor mismatch insertions
Looking at the colour-coded expression chart (Figure 2),
we can see a clear pattern of positional signiﬁcance for
the siRNAs ability to knockdown targets with diﬀerent
double-nucleotide mismatches. In accordance to earlier
studies (13), we can conﬁrm that position 5–11 seems to be
highly sensitive to nucleotide alterations and most of the
constructs with at least one mutation in this area causes
reduced knockdown eﬃciency, which results in remaining
luciferase expression levels of more than 50%. We can
see this pattern in both the vertical and horizontal levels.
Mutations in position 1–2 and 18–19 are the most
tolerable alterations but of course depending on were
the second mutation is positioned. Furthermore, double
mutations both situated in the 50-region of the siRNA
target site tend to cause greater knockdown inhibition
than double mutations in the 30-region of the same target.
The least changes in knockdown eﬃciency results when
one mutation occurs at position 1 or 2 and the other one is
positioned at the far 30-end. It is notable that double
mutations in region 1–3 or 17–19 seems to have greater
impact than when one of the mutations occurs in region
1–3 and the other in position 17–19. Another remarkable
observation is how well mutations in region 13–17
(medium tolerance region) are tolerated, especially when
the second mutation lies not only in region 1–3 but also
when the second mutation is positioned in region 13–17.
As reported previously (13), variations of knockdown
eﬃciency in the low tolerance regions may occur depend-
ing on which nucleotide is substituted and in what
position. In this study we can, for instance, see that the
substitution of guanosine to adenosine in position 8 for
siQ46-3C_8A and alteration of adenosine to guanosine in
position 11 for siQ46-2G_11G are examples of highly
tolerated mismatches in a low tolerance region. These
occurrences are, however, not as frequent in this study as
compared with analyses of siRNA targets with single-
nucleotide mismatches, most probably due to the addi-
tional nucleotide mismatch, which further aﬀects the
siRNA’s ability to recognize its target.
If we compare our results with earlier studies we can see
that the siRNA knockdown eﬃciency of our double-
mutated siRNA target constructs, follows the pattern of
previously identiﬁed tolerance regions (13). Mismatches in
the high tolerance regions aﬀect the speciﬁcity less than
mismatches in the low tolerance regions, which are critical
and often lead to full protein expression. Mutations in the
medium tolerance region diﬀer a lot in their ability to
aﬀect siRNA speciﬁcity depending on the identity of the
substituting nucleotide. We were, however, surprised to
see that a large part of the double-mutated target site still
causes little or no alterations in knockdown eﬃciency.
Comparison of site-specific alterations in siRNA
ortarget sequence
As discussed above, one of the beneﬁts of using a reporter-
based vector system for validation of siRNA target
speciﬁcity is the avoidance of altering the siRNA uptake
into RISC. Thermal stability of the siRNA duplex is
considered to be crucial for RISC assembly and uptake of
the correct antisense strand. By altering the siRNA
sequence, when performing studies of siRNA speciﬁcity
and investigations of possible oﬀ-target eﬀects, you might
also change its ability to enter RISC and hence aﬀect the
silencing eﬃciency negatively in an availability—rather
than speciﬁcity—based manner. To analyze this further,
we selected three diﬀerent siQuant constructs with varying
eﬀect on siCD46 knockdown eﬃciency: siQ46-9T_17A
gives total abolition of siRNA knockdown; siQ46-3A_14C
and siQ46-2C_8A are both silenced by  50%. Three
siRNAs corresponding to these double-mutated target
sites were designed to compare the knockdown eﬃciency
towards reporter constructs with wild type targets. The
results of this analysis indicate that in some of the cases,
there are indeed diﬀerences in knockdown eﬃciency
depending on whether the mutations is positioned on the
siRNA target or the siRNA itself (Figure 3). The
si-3A_14C gives a knockdown eﬃciency of 75% on its
wild type target as compared to the remaining 46%
knockdown eﬃciency when targeting siQ46-3A_14C with
the functional siCD46. To the opposite, si-2C_8A is only
able to knockdown the luciferase expression with 12%, as
compared to siQ46-2C_8A which results in 57% knock-
down. The si-9T_17A does not seem to alter any prefer-
ences for knockdown eﬃciency and has no eﬀect on the
expression levels as is the case also for the corresponding
siQ46-9T_17A. The results from these experiments indi-
cate that the sequence alterations in si-3A_14C gives a
positive eﬀect in terms of knockdown eﬃciency and the
Figure 3. Comparative study of mutations occurring in the siRNA
antisense strand or in the corresponding positions of its target site.
Light gray bars: siQ46-9T_17A and si-9T_17A, medium gray bars:
siQ46-3A_14C and si-3A-14C, dark gray bars: siQ46-2C_8A and
si-2C_8A, white bar: siQ46-wt co-transfected with unrelated siRNA.
T—mutation of siRNA target, S—mutation of siRNA antisense strand.
The bars represent remaining expression levels of ﬁreﬂy luciferase
activity normalized to renilla luciferase. All values are also normalized
to each reporter construct’s own ability to express luciferase.
 P<0.05
and
  P<0.01, respectively are signiﬁcant diﬀerences of luciferase
expression between cells transfected with either mutated siQuant target
constructs or mutated siRNAs.
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impact on its silencing ability.
DISCUSSION
Earlier studies about siRNA speciﬁcity show that the
location of the mutation is of great importance (10).
The 30 and central regions of the siRNA antisense strand
are considered highly sensitive for sequence alterations and
to cause great impact on knockdown eﬃciency (15,16).
When using siRNA as a tool for functional genomics
studies, molecules should at least give more than 70%
knockdown of its target expression to be considered as an
eﬀective siRNA. However, when evaluating the possible
oﬀ-target eﬀects of a single siRNA, >50% knockdown of
various oﬀ-targeted gene is a fairly large knockdown eﬀect
and might cause major alterations in cell function. In this
study we only examine the mismatch tolerance of a single
siRNA, which might not be a representative of all siRNAs.
Even so, the fact that we from our present study could see
that  35% of nonspeciﬁc targets with double-nucleotide
mismatches were down regulated with more than 50%
eﬃciency, demonstrates the need for careful investigation
of possible unwanted side eﬀects caused by siRNAs. This
is a particularly important matter to consider before
any eﬀorts of using siRNA-mediated gene silencing as a
therapeutic tool can be made.
By using the siRNA-target library construction method
described above, combining the siQuant reporter vector
with a single-tube oligomix, we were able to produce a
large set of reporter constructs in a high-throughput and
cost-eﬀective manner. 709 double-mismatched targets
were derived out of 1539 possible combinations. In
theory, all 1539 permutations should be included in our
target library, but the time and eﬀort for getting
additional clones eventually reached a steady-state level.
As we started to examine the 709 targets, we found that
they could already give a very clear trend.
Subsequent validation experiments have given us fur-
ther insight in siRNA oﬀ-target eﬀects. There seems to be
two types of oﬀ-target eﬀects from siRNA: (i) oﬀ-target
eﬀects mediated by Ago2 on targets that are highly similar
to the wild type targets of the siRNA. This type of
oﬀ-target eﬀects seems to be very potent although the
relative abundance of such ‘oﬀ-targets’ is relatively low.
(ii) oﬀ-target eﬀects mediated by Ago1 (or maybe partially
by Ago2 or other Ago’s) on targets that contain the ‘seed
region’ (8,17). Clearly, not all sequences that contain a
seed region will be aﬀected by a siRNA and currently
there are no clear indications about what are the addi-
tional determinants that would render a mRNA an
‘oﬀ-target’ of this type. In addition, oﬀ-target eﬀects of
this type are normally pretty weak. Also there is no
knowledge about when the type-1 oﬀ-target eﬀects will
fade and the type-2 oﬀ-target eﬀects take over. The
current article is a useful exploration about the scope of
type-1 oﬀ-target eﬀects. Results of this article cannot be
deduced from the study of type-2 oﬀ-target eﬀects.
We have also shown that nucleotide mismatches in the
antisense strand of the siRNA molecule can give a diﬀerent
knockdown pattern when comparing it to a wild type
siRNAs ability to suppress expression from target sites
with corresponding mutations. These data indicates that
the usage of mutated siRNA molecules is a less reliable tool
for evaluating siRNA speciﬁcity and further strengthens
the advantages of using the siQuant siRNA validation
vectors for these purposes.
Numerous studies exploring the functions of siRNA-
mediated RNAi have resulted in a large amount of factors
that all need to be taken under consideration when evalu-
ating siRNA speciﬁcity. In an indirect approach, compre-
hensive mutations were done on siRNAs and the mutated
versions of each siRNA were analyzed for their silencing
eﬃciency on native targets of the siRNA (17). Of 171
mutated siRNAs, silencing eﬃciency of about 60% of the
siRNAs (102 siRNAs) were above 50%, which suggested
that many mutated siRNAs have signiﬁcant ‘oﬀ-target’
eﬀects on native target transcripts. These observations
largely conﬁrm the results from our system in terms of the
widespread oﬀ-target eﬀects of siRNAs and signiﬁcance of
positions as well as nature of mismatches in determin-
ing the level of oﬀ-target eﬀects. However, it should be
stressed that the results from a siRNA mutating approach
should be viewed as the oﬀ-target eﬀects of many siRNAs
on a single target whereas our study provides a compre-
hensive view of the oﬀ-target eﬀects of a single siRNA.
In assessment of the speciﬁcity of future siRNA drugs,
approaches employed in the current study could poten-
tially be more applicable.
Except from sequence similarities between siRNAs and
nontargeted mRNAs as discussed in this article, there are
also other parameters like strand length, 30 overhangs,
internal stability of siRNA strands and siRNA seed region
complementarity to 30 UTR of mRNAs to take under
consideration when designing an siRNA of high speciﬁcity
and eﬃciency (17–21). It has also been suggested that
surrounding sequences and mRNA secondary structure
may have an impact on siRNA targeting and that mRNA-
binding proteins might interfere with the accessibility of
the siRNA target site. There are probably several other
features of RNAi action to be determined and in order be
able to predict siRNA speciﬁcity and possible oﬀ-target
eﬀects, computational methods combining all of these
parameters need to be established (22,23).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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